Early Intravenous Ibuprofen Decreases Narcotic Requirement and Length of Stay after Traumatic Rib Fracture

Author:

Bayouth Lilly1,Safcsak Karen2,Cheatham Michael L.2,Smith Chadwick P.2,Birrer Kara L.2,Promes John T.2

Affiliation:

1. University of Central Florida School of Medicine, Orlando, Florida;

2. Department of Surgical Education, Orlando Regional Medical Center, Orlando, Florida

Abstract

Pain control after traumatic rib fracture is essential to avoid respiratory complications and prolonged hospitalization. Narcotics are commonly used, but adjunctive medications such as non-steroidal anti-inflammatory drugs may be beneficial. Twenty-one patients with traumatic rib fractures treated with both narcotics and intravenous ibuprofen (IVIb) (Treatment) were retrospectively compared with 21 age- and rib fracture-matched patients who received narcotics alone (Control). Pain medication requirements over the first 7 hospital days were evaluated. Mean daily IVIb dose was 2070 ± 880 mg. Daily intravenous morphine-equivalent requirement was 19 ± 16 vs 32 ± 24 mg ( P < 0.0001). Daily narcotic requirement was significantly decreased in the Treatment group on Days 3 through 7 ( P < 0.05). Total weekly narcotic requirement was significantly less among Treatment patients ( P = 0.004). Highest and lowest daily pain scores were lower in the Treatment group ( P < 0.05). Hospital length of stay was 4.4 ± 3.4 versus 5.4 ± 2.9 days ( P = 0.32). There were no significant complications associated with IVIb therapy. Early IVIb therapy in patients with traumatic rib fractures significantly decreases narcotic requirement and results in clinically significant decreases in hospital length of stay. IVIb therapy should be initiated in patients with traumatic rib fractures to improve patient comfort and reduce narcotic requirement.

Publisher

SAGE Publications

Subject

General Medicine

Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3